ArticleThe World Allergy Organization journal2026

Efficacy predictions for omalizumab treatment based on basophil CD203c expression in patients with allergic rhinitis by basophil activation test -- a real-life, pilot study.

Zhan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.